Potential implications of GRP58 expression and susceptibility of cervical cancer to cisplatin and thymoquinone-based therapy
A new therapeutic approach of looking at the expression of glucose-regulated protein (GRP) 58 as an indication of cisplatin sensitivity may eradicate fruitless treatment and side effects in patients with cervical cancer. Thymoquinone, the bioactive compound in Nigella sativa, has been reported to ha...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Published: |
Dove Medical Press
2014
|
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|